References
- Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A. Anasarca: not a nephrotic syndrome but dermatomyositis. Eur J Pediatr 2008;167:831–4.
- Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology (Oxford) 2001;40:1293–8.
- Chandrakasan S, Singh S, Ratho RK, Kumar S, Mishra B. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis. Rheumatol Int 2009;29:565–7.
- Dwivedi N, Michael C, Lew DB, Arnold S, Igarashi M, Bertorini T A fatal presentation of dermatomyositis with facial swelling. Int J Pediatr Otorhinolaryngol 2012;76:745–9.
- Bustos BR, Carrasco AC, Toledo RC. Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis [in Spanish]. An Pediatr (Barc) 2012;77:47–50.
- Sterba G, Rodriguez C, Sifontes S, Vigilanza P. Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J Rheumatol 2004;31:1014–15.
- Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012;13:289–98.
- Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 2011;50:417–19.
- Elst EF, Kamphuis SS, Prakken BJ, Wulffraat NM, van der Net J, Peters AC Case report: severe central nervous system involvement in juvenile dermatomyositis. J Rheumatol 2003;30:2059–63.
- Stevens CJ, Heran MK. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 2012;85:1566–75.